Target-switchable Gd(III)-DOTA/protein cage nanoparticle conjugates with multiple targeting affibody molecules as target selective T1 contrast agents for high-field MRI
- J. Control. Release, Volume 335, 10 July 2021, Pages 269-280 | https://doi.org/10.1016/j.jconrel.2021.05.029
